A single centre, prospective, open-label, parallel group, randomized study to compare the gastrointestinal tolerability of mycophenolate mofetil (MMF, CellCept) and enteric-coated mycophenolate sodium (EC-MPS, Myfortic) in maintenance transplant patients treated with calcineurin inhibitors
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mycophenolate sodium (Primary) ; Mycophenolate mofetil
- Indications Heart transplant rejection; Kidney-pancreas transplant rejection; Liver transplant rejection; Renal transplant rejection
- Focus Adverse reactions
- Acronyms MOTOR-MPA
- 13 Mar 2008 New trial record.